Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. - Wikidata - wikimedia - TriplyDB

Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis.

Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis.

http://www.wikidata.org/entity/Q41862338

about

A review on chemical-induced inflammatory bowel disease models in rodents Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel disease Replenishment of glutathione levels improves mucosal function in experimental acute colitis.Targeting oxidative stress attenuates trinitrobenzene sulphonic acid induced inflammatory bowel disease like symptoms in rats: role of quercetin Peroxynitrite and inflammatory bowel disease Effect of karanjin on 2,4,6-trinitrobenzenesulfonic acid-induced colitis in Balb/c mice.Alternative medicines as emerging therapies for inflammatory bowel diseases.Recent advances in inflammatory bowel disease.Recombinant adenovirus-mediated intestinal trefoil factor gene therapy for burn-induced intestinal mucosal injury Effects of antioxidant therapy on leukocyte myeloperoxidase and Cu/Zn-superoxide dismutase and plasma malondialdehyde levels in experimental colitis Protective effects of N-acetylcysteine on acetic acid-induced colitis in a porcine model.Evaluation of new therapies for inflammatory bowel disease.Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease.Redox biology of the intestine 5-ASA affects cell cycle progression in colorectal cells by reversibly activating a replication checkpoint.Effect of turmeric on colon histology, body weight, ulcer, IL-23, MPO and glutathione in acetic-acid-induced inflammatory bowel disease in rats Intestinal redox biology and oxidative stress Ameliorative effects of sodium ferulate on experimental colitis and their mechanisms in rats.Evaluation of anti-inflammatory effect of anti-platelet agent-clopidogrel in experimentally induced inflammatory bowel disease.Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer.Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells.Naringin ameliorates acetic acid induced colitis through modulation of endogenous oxido-nitrosative balance and DNA damage in rats.Effects of β-glucan pretreatment on acetylsalicylic acid-induced gastric damage: An experimental study in rats.Effects of humanin on experimental colitis induced by 2,4,6-trinitrobenzene sulphonic acid in rats.Comparative pharmaceutical study on colon targeted micro-particles of celecoxib: in-vitro-in-vivo evaluation.The possible role of mesenchymal stem cells therapy in the repair of experimentally induced colitis in male albino rats.Huangqin-Tang and Ingredients in Modulating the Pathogenesis of Ulcerative Colitis Beneficial effects of N-acetyl cysteine on pancreas and kidney following experimental pancreatic ischemia-reperfusion in rats.Protective effects of Aegle marmelos fruit pulp on 2,4,6-trinitrobenzene sulfonic acid-induced experimental colitis.Protective Effect of Ginger oil on Aspirin and Pylorus Ligation-Induced Gastric Ulcer model in Rats.The Extracts of Morinda officinalis and Its Hairy Roots Attenuate Dextran Sodium Sulfate-Induced Chronic Ulcerative Colitis in Mice by Regulating Inflammation and Lymphocyte Apoptosis.Garidisan: Improving the Quality of Ulcer Healing in Rats with Ulcerative Colitis Curcumin half analog modulates interleukin-6 and tumor necrosis factor-alpha in inflammatory bowel disease.Effects of melatonin on the expression of iNOS and COX-2 in rat models of colitis.Chemiluminescence response induced by mesenteric ischaemia/reperfusion: effect of antioxidative compounds ex vivo.Activation of nuclear factor-kappa B and effects of pyrrolidine dithiocarbamate on TNBS-induced rat colitis.Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: an in vitro study.Enemas with N-acetylcysteine can reduce the level of oxidative damage in cells of the colonic mucosa diverted from the faecal stream.Attenuating effects of coenzyme Q10 and amlodipine in ulcerative colitis model in rats.NOX1/NADPH Oxidase Expressed in Colonic Macrophages Contributes to the Pathogenesis of Colonic Inflammation in Trinitrobenzene Sulfonic Acid-Induced Murine Colitis.

P2860

Q26827500-82F08899-9A43-47A8-A8A6-588B94A966D7 Q28073219-4BDD9FAB-B66E-4CF2-A268-866FCEA9041F Q31388379-85F9F15D-7735-4B5D-8DD4-0C8FEE8F9CF9 Q33809401-0A0B3864-3341-47F1-8175-C32E6486CCED Q33836818-5DA0B497-A3EA-4B14-9FB7-8A7429F1DAAF Q33872261-4D0CC32B-AB9C-4072-BD3D-46953D6206B9 Q34069427-9F825122-214B-409F-A62F-8EDFD6778E9B Q34188405-BCB60488-8E60-4611-8576-10D787970290 Q34701466-C9509F19-14D1-4508-99A1-9E489BB3C485 Q34945561-9B8ABB73-E2DA-4D61-B93A-C0723C133355 Q34977682-8DF842D7-8B49-4B4E-A90F-F03AB134EF96 Q35216827-29366A32-2D34-420B-AD65-B033A93A5A16 Q35350433-3343325C-BDFA-4F5A-A209-15D209526CCB Q35534376-1AFA8D93-E473-41E2-A173-E12661D65209 Q35728207-7437C32B-E4DB-448D-AE02-3E30C53FCDCC Q35932970-F622A60D-84B4-4783-BFC0-A49F06193527 Q36095043-05293BC7-0CD2-46F0-BAE2-D567047ED159 Q36308863-D487BB6A-3167-4641-B06C-8973BBE2809C Q36470212-84F8ACEB-3A37-4050-AB7A-8D3FA1218B1D Q37148781-F0645378-D04D-46CB-8EE4-5A2662505141 Q37339787-3EC623F5-C084-4F7A-BE10-13F36505B6BB Q37669820-038A9FC7-9B8B-4FB6-95FA-207A61BF901E Q37672048-D657181C-C228-48C1-832B-BCF298BB7DBA Q37743596-2936A402-F8AD-422F-9CE9-706D601989BC Q38880054-8C067C4A-391B-4ECB-AC64-AFE23122D474 Q39280447-E041ED3D-650D-4DD6-A3C9-0EEA1FCAB6BB Q39424570-E882015C-4382-4378-9DCD-86E60BFE2E7B Q39804522-2D39BDF7-F91F-4121-8786-27FABE9C68D0 Q40204185-8901F03B-B09B-493F-9DF4-4FFE89892610 Q40431099-5D79F09B-3BC2-4BFE-A70F-51D47481A3BD Q41203716-4839B0C9-BFE2-45A8-A5A8-8EB96B18708B Q41451822-F89D124A-ED8E-4DD7-B45D-5D97FD19C844 Q41785133-F4BA2F39-9CE2-4045-9425-C510B78014E1 Q41904590-E619F9AF-4BCC-45BA-91D6-115BB8A52478 Q42357960-D2120F25-E091-415D-AE79-8633D4C9DF9C Q43118458-224EB141-9F97-4B0D-AE06-36783682ABFC Q43892491-9A7C6115-00E2-44E9-808E-D7A8C0059E5E Q45135707-CB8C2712-119A-490C-A470-460ECE89C72E Q46178594-CC39DE23-67FF-4E0C-B57B-19AFB589431F Q46476449-3C987400-E73C-4440-B260-7CC6CD8CD48C

P2860

Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis.

http://www.wikidata.org/entity/Q41862338

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

1996年论文

@zh

1996年论文

@zh-cn

name

Evaluating the antioxidant pot ...... using a rat model of colitis.

@en

type

label

Evaluating the antioxidant pot ...... using a rat model of colitis.

@en

prefLabel

Evaluating the antioxidant pot ...... using a rat model of colitis.

@en

P1433

Q41862338-65A444CE-C8CC-4858-AE6F-3AC7A5944451

P1476

Q41862338-A0A45A04-C1A9-4828-8207-C7ED7B7A248E

P2093

Q41862338-1530813D-C033-40BB-84E4-36DEF7410261

Q41862338-841034F7-2ACE-4D2C-AD78-1B202AD40F72

Q41862338-9C55CC89-FB03-486D-BF0A-984F3F40B432

Q41862338-A63EE7EE-D3C0-4614-B0E2-7C8176E14CB2

Q41862338-ABD031E5-18ED-432C-AA59-7BCBA805B024

Q41862338-CE56CEC3-9716-4A58-A887-3B353A2BD986

Q41862338-D3809C26-FDCC-48D5-A157-E611EDC16712

Q41862338-E61BB9D5-734D-4BF1-88C1-057014EC73E2

Q41862338-E6ED0A3A-FB1F-468B-A016-9AB49AE40AF3

P2860

Q41862338-02037F83-F322-45A9-9852-1422E897641C

Q41862338-0C2A7392-4D31-4E52-B2B4-AADDC7601682

Q41862338-0FF03D2D-A56B-4651-B025-691DF2915E7F

Q41862338-12F97372-8CFD-4910-98BD-75EB589711F6

Q41862338-1E125ED3-1DD8-4522-A766-5F2895245930

Q41862338-1EEC5B19-C6A9-4F5C-984E-9AA7BF3AC62D

Q41862338-1EF575A4-7ABA-470D-B2C4-FFAF1406F6E6

Q41862338-2D1CFB34-9A3A-4DFC-9837-7D68B13052C9

Q41862338-332C1E5D-6CD5-4922-BCE4-B4D7E7CA7E0F

Q41862338-3B6880F6-FB8E-4084-A124-3900E910B094

P304

Q41862338-70136467-49EF-412D-A859-522061A1BDC8

P31

Q41862338-BE9DF719-99CF-4DD4-B9B5-6C231A1486EE

P356

Q41862338-E044E8F1-DDE8-4677-B14B-ABB092E3436C

P407

Q41862338-84FC2EC4-1A19-4C61-86AC-C14953C6DBB1

P433

Q41862338-03E1C64B-C6A9-4338-89DD-81D5361E2CDA

P478

Q41862338-BECF9614-8CCC-4A10-861C-EF8B541FEC92

P577

Q41862338-C2188172-AFB9-4C85-9A7E-5F6749DB78E6

P5875

Q41862338-A453DD09-3CB2-4BB8-83E9-143E2BF072D9

P698

Q41862338-45B54AB5-582F-479F-B791-234DC4B9551E

P921

Q41862338-77841ED6-7B28-4D66-B9EC-C953F36A282C

Q41862338-F3291088-A3A4-42ED-AC97-BA15F07E24EA

P932

Q41862338-087BDCC7-3BB7-4657-894A-82B2F49D1D40

P356

P1433

P1476

Evaluating the antioxidant pot ...... using a rat model of colitis.

@en

P2093

Blades S

http://www.w3.org/2001/XMLSchema#string

Blake DR

http://www.w3.org/2001/XMLSchema#string

Chander CL

http://www.w3.org/2001/XMLSchema#string

Claxson AW

http://www.w3.org/2001/XMLSchema#string

Coumbe A

http://www.w3.org/2001/XMLSchema#string

Millar AD

http://www.w3.org/2001/XMLSchema#string

Morris CJ

http://www.w3.org/2001/XMLSchema#string

Panetta J

http://www.w3.org/2001/XMLSchema#string

Rampton DS

http://www.w3.org/2001/XMLSchema#string

P2860

Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1

Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction.

Effects of dimethyl sulfoxide on the oxidative function of human neutrophils.

Location of superoxide anion generation in human colonic mucosa obtained by biopsy.

Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis.

Role of reactive oxygen metabolites in experimental colitis.

Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion

Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease.

Antioxidant role and subcellular location of hypotaurine and taurine in human neutrophils.

Oxygen radicals in ulcerative colitis.

P304

407-415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.39.3.407

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

1996-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14257087

http://www.w3.org/2001/XMLSchema#string

P698

8949646

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

P932

1383348

http://www.w3.org/2001/XMLSchema#string